The postponed 2020 World Conference on Lung Cancer finally took place, shared globally from its host location in Singapore. It ran from Thursday 28 through to Sunday 31 January, but you can still view the sessions and presentations online by following this link.
The virtual conference will remain available online until April 30, 2021 @ 17:00 Singapore Time
You can also download the event programme as a pdf document here:
Highlights of Day Three included sessions featuring our chair, Prof Matthew Peters, and our colleague Sarah Winstone, Founding Partner of Incisive Health, the communications agency that provides support for many of our research studies and surveys.
Sarah and her colleagues at Incisive Health have provided much of the content and data for our Lung Cancer Screening Resource microsite, which links from our main site – or click here.
You can still view these sessions by logging on via the link above and navigating to the Scientific Program Auditorium.
Education Sessions – ES16 – Joint GLCC / IASLC session: Hot Topics for Advocates.
Chair: Matthew Peters.
Campaigning for lung cancer screening – A Tool For Advocates, presented by Sarah Winstone.
NB: If you want to see this presentation use the MEDIA PLAYER (available within the column of icons on the left side of the screen) to scroll forward to 00.13. 20.
Sarah outlined our Screening micro-site, which is, as she said, an open-access data resource to support advocacy for lung cancer screening.
ES19 – Patient-Reported Outcomes, Patient Registries and Real-World Evidence: Learning Directly from Patients.
Mini Oral Session
MA07 – Improving Care for People with Lung Cancer: Decision Making, Survivorship, and New Challenges During COVID-19.
MA07.07 – Assessing the Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations. This was presented by Matthew Peters.
NB: If you want to see this presentation use the MEDIA PLAYER (available within the column of icons on the left side of the screen) to scroll forward to 00.42.45.
Matthew outlined the findings from the GLCC survey on the impact of the pandemic on global lung cancer patient advocacy and support organisations.